Activaero appoints chief business officer
Christian Pangratz takes the role
Pangratz joins Activaero from Nektar Therapeutics, in San Francisco, US, where he recently served as executive director of business development. He brings to Activaero 20 years of life science experience.
Pangratz will join the Activaero management team and lead all business development, marketing and alliance management activities. He replaces Henrik Luessen, who has decided to focus on his own consultancy firm, but will continue to support Activaero’s business development team on a part-time basis.
You may also like
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.
Regulatory
![What Operation TrialBlazer means for CDMOs and CMC strategy]()
What Operation TrialBlazer means for CDMOs and CMC strategy
The FDA's new framework cuts Phase I data requirements, opens platform manufacturing data reuse and creates a new CRO/CDMO review role as HHS moves to close the gap with China's faster clinical trial pipeline — but how will this affect the pharma sector?
Digital
![Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations]()
Shilpa Biologicals launches PartnerPower real-time visibility platform for biologics CDMO operations
The digital data fabric links R&D, analytical development and GMP manufacturing, replacing periodic reporting with continuous audit-ready transparency aligned to FDA, EMA and PMDA expectations
Manufacturing
![Piramal Pharma Solutions highlights strong performance across more than 200 customer audits]()
Piramal Pharma Solutions highlights strong performance across more than 200 customer audits
Piramal Pharma Solutions completed more than 200 customer audits and received over 70 approvals from regulatory agencies across its global network over the past year, with strong overall outcomes
